publication venue for
- Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma.. 261. 2023
- Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.. 260. 2023
- Differential involvement of LUBAC-mediated linear ubiquitination in intestinal epithelial cells and macrophages during intestinal inflammation.. 259. 2022
- Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix. 2022
- Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies. 2022
- Independent real-world application of a clinical-grade automated prostate cancer detection system.. 254. 2021
- Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss.. 253. 2020
- POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.. 249. 2019
- Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.. 249. 2019
- Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.. 248. 2019
- Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.. 246. 2018
- MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.. 244. 2017
- The genetic landscape of endometrial clear cell carcinomas.. 243. 2017
- Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.. 242. 2017
- Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.. 242. 2017
- Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repair.. 242. 2017
- The genetic landscape of breast carcinomas with neuroendocrine differentiation.. 241. 2016
- Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.. 238. 2016
- The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.. 237. 2015
- Genomic landscape of adenoid cystic carcinoma of the breast.. 237. 2015
- Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.. 236. 2015
- Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.. 236. 2015
- Targeted genomic analysis of Müllerian adenosarcoma.. 235. 2014
- c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.. 234. 2014
- Neutrophil extracellular traps promote differentiation and function of fibroblasts.. 233. 2014
- Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells.. 229. 2012
- From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.. 227. 2012
- Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.. 227. 2012
- Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.. 224. 2011
- Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.. 222. 2010
- IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting.. 221. 2010
- BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.. 221. 2010
- c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.. 218. 2009
- The basal-like breast carcinoma phenotype is regulated by SLUG gene expression.. 214. 2008
- Morphological features of TMPRSS2-ERG gene fusion prostate cancer.. 212. 2007
- TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease.. 210. 2006
- Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.. 210. 2006
- Gastrointestinal stromal tumours overexpress fatty acid synthase.. 209. 2006
- Expression and regulation of human beta-defensin-2 in osteoarthritic cartilage.. 209. 2006
- DNA replication licensing in peripheral B-cell lymphoma.. 205. 2005
- MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.. 205. 2005
- Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.. 205. 2005
- Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes.. 202. 2004
- Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma.. 202. 2004
- Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.. 198. 2002
- Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer.. 198. 2002
- Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa.. 192. 2000
- Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology.. 190. 2000
- Differential expression of the c-kit proto-oncogene in germ cell tumours.. 177. 1995
- MDM2 and CDK4 gene amplification in Ewing's sarcoma.. 175. 1995
- Exploring the role of chitinase-3-like protein 1 in recurrence patterns among patients with differentiated thyroid cancer†.. 252. 2020
- Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456.. 231. 2013
- The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice. 2020
- The value of cell-free DNA for molecular pathology. 2018
- Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision. 2018
- Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. 2014
- The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis. 2013
- Metabolic alterations and targeted therapies in prostate cancer. 2010
- KRAS and BRAF: drug targets and predictive biomarkers. 2010
- Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer. 2024
- Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group. 2023
- Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. 2023